A detailed history of Los Angeles Capital Management LLC transactions in Axogen, Inc. stock. As of the latest transaction made, Los Angeles Capital Management LLC holds 19,870 shares of AXGN stock, worth $295,069. This represents 0.0% of its overall portfolio holdings.

Number of Shares
19,870
Holding current value
$295,069
% of portfolio
0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

BUY
$7.52 - $14.69 $149,422 - $291,890
19,870 New
19,870 $278,000
Q2 2023

Aug 03, 2023

BUY
$8.5 - $10.38 $550,749 - $672,561
64,794 New
64,794 $591,000
Q4 2021

Feb 03, 2022

SELL
$8.8 - $16.0 $184,817 - $336,032
-21,002 Closed
0 $0
Q3 2021

Nov 08, 2021

BUY
$15.23 - $21.72 $118,794 - $169,416
7,800 Added 59.08%
21,002 $332,000
Q2 2021

Aug 05, 2021

BUY
$17.8 - $23.5 $234,995 - $310,247
13,202 New
13,202 $285,000

Others Institutions Holding AXGN

About Axogen, Inc.


  • Ticker AXGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 42,283,700
  • Market Cap $628M
  • Description
  • AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...
More about AXGN
Track This Portfolio

Track Los Angeles Capital Management LLC Portfolio

Follow Los Angeles Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Los Angeles Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Los Angeles Capital Management LLC with notifications on news.